4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening

Pál Megyeri, László Németh, Karen M. Pabst, Michael J. Pabst, M. Deli, C. Ábrahám

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effect of serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) was investigated on the prevention of tumor-necrosis-factor-α (TNF-α)-induced blood-brain barrier opening. TNF-α (10,000 IU) was injected intracarotidly to newborn pigs pretreated with 0, 2.4, 4.8, 9.6 and 19.2 mg/kg AEBSF (n=6 in each group). AEBSF dose-dependently inhibited the TNF-α-induced increase in the blood-brain barrier permeability for sodium fluorescein (MW=376) in all of the five brain regions examined, while only 19.2 mg/kg AEBSF could significantly (P

Original languageEnglish
Pages (from-to)207-211
Number of pages5
JournalEuropean Journal of Pharmacology
Volume374
Issue number2
DOIs
Publication statusPublished - Jun 18 1999

Fingerprint

Blood-Brain Barrier
Fluorides
Tumor Necrosis Factor-alpha
Serine Proteinase Inhibitors
Fluorescein
Permeability
Swine
Brain
4-(2-aminoethyl)benzenesulfonylfluoride

Keywords

  • AEBSF [4-(2-aminoethyl)benzenesulfonyl] fluoride
  • Blood-brain barrier
  • Brain edema
  • Serine protease inhibitor
  • TNF-α (tumor necrosis factor-α)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening. / Megyeri, Pál; Németh, László; Pabst, Karen M.; Pabst, Michael J.; Deli, M.; Ábrahám, C.

In: European Journal of Pharmacology, Vol. 374, No. 2, 18.06.1999, p. 207-211.

Research output: Contribution to journalArticle

Megyeri, Pál ; Németh, László ; Pabst, Karen M. ; Pabst, Michael J. ; Deli, M. ; Ábrahám, C. / 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening. In: European Journal of Pharmacology. 1999 ; Vol. 374, No. 2. pp. 207-211.
@article{ac254704b09a478b87c75f00b73b5e62,
title = "4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening",
abstract = "The effect of serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) was investigated on the prevention of tumor-necrosis-factor-α (TNF-α)-induced blood-brain barrier opening. TNF-α (10,000 IU) was injected intracarotidly to newborn pigs pretreated with 0, 2.4, 4.8, 9.6 and 19.2 mg/kg AEBSF (n=6 in each group). AEBSF dose-dependently inhibited the TNF-α-induced increase in the blood-brain barrier permeability for sodium fluorescein (MW=376) in all of the five brain regions examined, while only 19.2 mg/kg AEBSF could significantly (P",
keywords = "AEBSF [4-(2-aminoethyl)benzenesulfonyl] fluoride, Blood-brain barrier, Brain edema, Serine protease inhibitor, TNF-α (tumor necrosis factor-α)",
author = "P{\'a}l Megyeri and L{\'a}szl{\'o} N{\'e}meth and Pabst, {Karen M.} and Pabst, {Michael J.} and M. Deli and C. {\'A}brah{\'a}m",
year = "1999",
month = "6",
day = "18",
doi = "10.1016/S0014-2999(99)00224-1",
language = "English",
volume = "374",
pages = "207--211",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening

AU - Megyeri, Pál

AU - Németh, László

AU - Pabst, Karen M.

AU - Pabst, Michael J.

AU - Deli, M.

AU - Ábrahám, C.

PY - 1999/6/18

Y1 - 1999/6/18

N2 - The effect of serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) was investigated on the prevention of tumor-necrosis-factor-α (TNF-α)-induced blood-brain barrier opening. TNF-α (10,000 IU) was injected intracarotidly to newborn pigs pretreated with 0, 2.4, 4.8, 9.6 and 19.2 mg/kg AEBSF (n=6 in each group). AEBSF dose-dependently inhibited the TNF-α-induced increase in the blood-brain barrier permeability for sodium fluorescein (MW=376) in all of the five brain regions examined, while only 19.2 mg/kg AEBSF could significantly (P

AB - The effect of serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) was investigated on the prevention of tumor-necrosis-factor-α (TNF-α)-induced blood-brain barrier opening. TNF-α (10,000 IU) was injected intracarotidly to newborn pigs pretreated with 0, 2.4, 4.8, 9.6 and 19.2 mg/kg AEBSF (n=6 in each group). AEBSF dose-dependently inhibited the TNF-α-induced increase in the blood-brain barrier permeability for sodium fluorescein (MW=376) in all of the five brain regions examined, while only 19.2 mg/kg AEBSF could significantly (P

KW - AEBSF [4-(2-aminoethyl)benzenesulfonyl] fluoride

KW - Blood-brain barrier

KW - Brain edema

KW - Serine protease inhibitor

KW - TNF-α (tumor necrosis factor-α)

UR - http://www.scopus.com/inward/record.url?scp=0345189537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345189537&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(99)00224-1

DO - 10.1016/S0014-2999(99)00224-1

M3 - Article

VL - 374

SP - 207

EP - 211

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -